Over 80% of patients manifest a transient rise in blood pressure (BP) after ischemic stroke, regardless of their previous blood pressure level. In the spontaneously hypertensive rat (SHR), we investigate the cardiovascular response to stroke in animals already receiving chronic anti‐hypertensive treatment and evaluate the impact of actively controlling BP after stroke in these animals.Male SH rats (n=16, 374±5 g) were instrumented to allow the long‐term recording of BP and brain tissue oxygen in the penumbra (pO2) via telemetry. Resting BP was controlled for four weeks using the angiotensin‐converting enzyme inhibitor enalapril (10mg/kg/day in drinking water). After recording a 3‐day baseline, on D0, an ischemic stroke was induced via a two‐hour transient occlusion of the middle cerebral artery (MCAo). After a stroke, treatment with enalapril was continued in all rats (10mg/kg/day sc via osmotic pump) either alone (Untreated, n=8) or in conjunction with the clinically‐indicated adrenergic antagonist, labetalol (0.25mg/kg/hr sc via osmotic pump) to prevent post‐stroke hypertension (Treated n=8). Behavioural testing and neurological scoring (SHIRPA score) were performed on Days 1, 3, 7 and 10 to evaluate the functional recovery over time, and post‐mortem stroke infarct size was assessed by histology on D10.Enalapril treatment significantly and consistently reduced baseline BP to a normotensive level (from 142±1 to 116±3 mmHg, p<0.001). Following a stroke, BP increased rapidly in the Untreated rats, reaching a peak of 14±3 mmHg above baseline on Days 0 and 1 (p<0.05). Post‐stroke hypertension was successfully prevented in the Treated group, with BP significantly lower than in Untreated rats (p<0.05). Penumbra tissue oxygen levels were increased significantly above baseline in Treated animals on D1 and D2 (p<0.05), consistent with previous reports that labetalol preserves or increases cerebral blood flow despite lowering BP. Untreated and Treated rats showed a similar pattern of functional impairment and recovery after stroke, however, the infarct volume was significantly smaller in Treated animals on D10 (276±8mm3 vs Treated 220±16mm3, p<0.05).We show that a pronounced increase in BP occurs after stroke in controlled hypertensive animals. We hypothesized that this post‐stroke hypertension may be a protective response, aiding perfusion of the ischemic penumbra. Our results showed that preventing post‐stroke hypertension did not appear to have a negative impact on the functional recovery from stroke and that labetalol treatment may in fact enhance cerebral blood flow.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Read full abstract